# Thomas Grosse-Puppendahl

> Thomas Grosse-Puppendahl is a seed investor at Evonik Venture Capital backing 3D Printing. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Evonik Venture Capital](https://shizune.co/investors/profile/evonik-venture-capital-gmbh)
- Location: Essen, Germany
- Total investments: 3
- Last investment: Aug 2021
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/thomas-grosse-puppendahl-548189181/

Thomas Grosse-Puppendahl is a Vice President at Evonik.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| 3D Printing | 2 | 67% |
| Medical | 1 | 33% |
| Software | 1 | 33% |
| Health Care | 1 | 33% |
| Manufacturing | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 1 | 33% |
| Israel | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Castor Technologies LTD | CASTOR’s proprietary technology helps manufacturers assess how to apply advanced manufacturing to their production processes. By providing a comprehensive technical and cost-savings assessment for a full bill of materials, designers, NPI managers and production engineers have the critical information they need to effectively and efficiently makemachine parts. | $3.5M | Seed | Aug 16, 2021 |  |
| Castor Technologies LTD | CASTOR’s proprietary technology helps manufacturers assess how to apply advanced manufacturing to their production processes. By providing a comprehensive technical and cost-savings assessment for a full bill of materials, designers, NPI managers and production engineers have the critical information they need to effectively and efficiently makemachine parts. | $2M | Seed | Oct 24, 2019 |  |
| Medvance | Medvance is one of the pioneers in the development of 3D printed PEEK medical implants. Evonik has always been our trusted raw material partner. This investment will further promote The company's development has helped us bring innovative solutions to patients and doctors in China and then to the world." |  | Series A | Sep 06, 2019 |  |

3 of 3 investments shown.

## Co-investors
- [TAU Ventures](https://shizune.co/investors/profile/tau-ventures) — VC Fund, 2 deals together
- [Puhua Capital](https://shizune.co/investors/profile/puhua-capital) — VC Fund, 1 deal together
- [Spring Ventures](https://shizune.co/investors/profile/spring-ventures-2) — VC Fund, 1 deal together
- [The Chartered Group](https://shizune.co/investors/profile/the-chartered-group) — VC Fund, 1 deal together
- [Xerox](https://shizune.co/investors/profile/xerox) — VC Fund, 1 deal together
- [Zhongnuo Venture Capital](https://shizune.co/investors/profile/zhongnuo-venture-capital) — VC Fund, 1 deal together

## About Evonik Venture Capital

VC Fund · Hanau, Germany

Evonik Venture Capital is the corporate venture arm of Evonik Industries AG, one of the providers of specialty chemicals. Evonik Venture Capital invests in young companies with innovative technology and high growth potential with solutions to problems within the areas of focus of resource efficiency, specialty additives, health & care,nutrition.

5 contacts available at Evonik Venture Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Bernhard Mohr | Managing Director | https://shizune.co/investors/profile/dr-bernhard-mohr |
| Eric Breese | Investment Director | https://shizune.co/investors/profile/eric-breese |
| Lars Bönisch | Venture Capitalist | https://shizune.co/investors/profile/lars-b%C3%B6nisch |
| Lutz Stoeber | Investment Director | https://shizune.co/investors/profile/lutz-stoeber |
| Thomas Grosse-Puppendahl | Vice President, Operations | https://shizune.co/investors/profile/thomas-grosse-puppendahl |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Thomas Grosse-Puppendahl invest in?

Thomas Grosse-Puppendahl invests primarily in 3D Printing, Medical and Software startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Thomas Grosse-Puppendahl last invest?

The most recent investment recorded for Thomas Grosse-Puppendahl closed in Aug 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co